Login
Navigate Fool.com
Will GNVC beat
the market?

GENVEC, INC.

NASDAQ: GNVC

Community Rating: 1 Star: Ominous

2.66 0.16 (6.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.50
Previous Close $2.50
Daily Range $2.50 - $2.75
52-Week Range $0.25 - $4.25
Market Cap $45.9M
P/E Ratio -3.45
Dividend (Yield) $0.00 (0.0%)
Volume 48,677
Average Daily Volume 129,786
Current FY EPS -$0.05

How do you think GNVC
will perform against the market?

Top GNVC Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted November 11, 2011

Sorry, but I like this pitch so much I have to keep using it. GenVec is like one of those old war criminals that settles into an obscure life teaching piano in a remote village. Chest-pounding pronou … More

0 Replies Reply Report this Post
 

1337172979 (< 20)
Submitted June 3, 2011

ahh, Genvec, Genvec, where do I start? Since the TNFerade program failed in phase 3 for pancreatic cancer, the stock has left about 80% of shareholders' money on the way. After a reverse split, it see … More

0 Replies Reply Report this Post

News & Commentary

GenVec Q4 Net Loss Deepens

The pharmaceutical company lands firmly in the red, but the net result isn't as bad as expected.

Pre-Market Earnings Report for March 28, 2014 : BBRY, FINL, GNVC, JBSAY

Pre-Market Earnings Report for March 28, 2014 : BBRY, FINL, GNVC, JBSAY

Sector Update: Biotech Stocks Helping The NASDAQ

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX,

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

Pre-Market Earnings Report for March 22, 2013 : TIF, DRI, GNVC

Pre-Market Earnings Report for March 22, 2013 : TIF, DRI, GNVC

GenVec Gets Conditional License For Foot-And-Mouth Vaccine For Cattle

GenVec, Merial Team up to Develop Food-and-Mouth Disease Vaccine

3 Stocks to Play Biotech

Here are three promising ideas for this exciting area.

UPDATE 1-GenVec shrs plunge after cancer drug trial discontinued

GenVec Halts Phase III Trial Of TNFerade For Pancreatic Cancer

See More GNVC News...

Sector

Healthcare

Industry

Drugs

GENVEC, INC. (GNVC) Description

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines. Website: http://www.genvec.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks